The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

Considering taking supplements to treat diabetic retinopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of diabetic retinopathy. Follow the links to read ...

Diabetic retinopathy involves the changes for the blood vessels in your eye due to the high sugars that are in your body from diabetes, if you're a diabetic and you notice changes to your vision ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

With the advent of the 21st century, healthcare practitioners have witnessed a dramatic increase in the number of people being diagnosed with diabetes globally. According to the International ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

Fenofibrate is known to increase serum creatinine, but this effect is fully reversible, even after long-term treatment. The mechanism underlying this is poorly understood, but fenofibrate is not ...